JB
Jisha Balachandran
About Jisha Balachandran
Data last updated:
Jisha Balachandran is a Designated Partner at Kramelt Pharmaceuticals Llp (since 2025) and Director at Quinlabb Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma and Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kramelt Pharmaceuticals Llp ACL-1997 | Designated Partner | 01 Jan 2025 | 2025 | Active | |
| Quinlabb Pharmaceuticals Private Limited U24290KL2021PTC067906 | Director | 08 Mar 2021 | 2021 | Active |
Board colleagues of Jisha Balachandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishnakumar Velakkathaleth | 10893242 | Kramelt Pharmaceuticals Llp | Designated Partner |
| Mani Krishna Varrier | 09096619 | Quinlabb Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jisha Balachandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jisha Balachandran
Jisha Balachandran currently holds 2 directorships: Kramelt Pharmaceuticals Llp (Designated Partner, since 01 Jan 2025); Quinlabb Pharmaceuticals Private Limited (Director, since 08 Mar 2021).
Jisha Balachandran was first appointed on 08 Mar 2021 as Director at Quinlabb Pharmaceuticals Private Limited. The most recent appointment on record is 01 Jan 2025 at Kramelt Pharmaceuticals Llp.
The current boards of Jisha Balachandran's companies include Krishnakumar Velakkathaleth (Kramelt Pharmaceuticals Llp), Mani Krishna Varrier (Quinlabb Pharmaceuticals Private Limited).